scholarly journals Letter by Magalhaes et al Regarding Article, “Long-Term Survival and Repeat Coronary Revascularization in Dialysis Patients After Surgical and Percutaneous Coronary Revascularization With Drug-Eluting and Bare Metal Stents in the United States”

Circulation ◽  
2013 ◽  
Vol 128 (20) ◽  
Author(s):  
Marco A. Magalhaes ◽  
Israel M. Barbash ◽  
Ron Waksman
Keyword(s):  
Coronary Revascularization ◽  
Bare Metal Stents ◽  
The United States ◽  
Metal Stents ◽  
Dialysis Patients ◽  
Term Survival ◽  
Percutaneous Coronary Revascularization ◽  
Percutaneous Coronary ◽  
Drug Eluting

scholarly journals Aspects of Heart Failure in Patients with Ischemic Heart Disease after Percutaneous Coronary Revascularization with Polymer-coated Drug-Eluting Stents versus Bare-Metal Stents

2019 ◽  
Vol 56 (1) ◽  
pp. 37-40
Author(s):  
Mariana Tudoran ◽  
Cristina Tudoran ◽  
Tudor Ciocarlie ◽  
Gheorghe Nicusor Pop ◽  
marcel Mihai Berceanu-Vaduva ◽  
...  
Keyword(s):  
Heart Failure ◽  
Heart Disease ◽  
Coronary Revascularization ◽  
Bare Metal Stents ◽  
Drug Eluting Stents ◽  
Metal Stents ◽  
Bare Metal ◽  
Percutaneous Coronary Revascularization ◽  
Percutaneous Coronary ◽  
Drug Eluting

Percutaneous coronary revascularization (PCR) with polymer-coated drug-eluting stents (DES) or bare-metal stents (BMS) is considered the standard therapy in advanced ischemic heart disease (IHD). Despite revascularisation, many of these patients subsequently develop heart failure with reduced ejection fraction (HFrEF). We analysed 51 patients with IHD, treated by PCR and insertion of DES and/or BMS who later developed HFrEF. Patients with DES where more likely women, of younger age and a higher incidence of diabetes mellitus compared to patients with BMS who were generally men, of older age and had more frequently acute ST-elevation myocardial infarction (STEMI) as indication for PCR. Although patients with DES had more severe IHD, their EF was higher, possibly due to the benefits offered by the DES.

Outcomes of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bare Metal Stents for Acute Coronary Syndrome in Octogenarians

Angiology ◽  
2011 ◽  
Vol 62 (8) ◽  
pp. 620-624 ◽  
Author(s):  
Yuichiro Maekawa ◽  
Akio Kawamura ◽  
Shinsuke Yuasa ◽  
Yohei Ohno ◽  
Takahide Arai ◽  
...  
Keyword(s):  
Bare Metal Stents ◽  
Drug Eluting Stents ◽  
Metal Stents ◽  
Bare Metal ◽  
Long Term Outcomes ◽  
Coronary Syndrome ◽  
Percutaneous Coronary ◽  
Drug Eluting ◽  
Short And Long Term

The number of percutaneous coronary interventions (PCI) performed for octogenarians with acute coronary syndrome (ACS) continue to increase. The short- and long-term outcomes of intravascular ultrasound (IVUS)-guided PCI with drug-eluting stents (DES) or bare metal stents (BMS) for ACS in octogenarians, however, remain largely unknown. We analyzed clinical outcomes of octogenarians undergoing IVUS-guided PCI for ACS with either DES or BMS. During the study period, a total of 776 patients with ACS underwent IVUS-guided PCI and 75 of them were octogenarians. In-hospital mortality tended to be lower in the DES group than in the BMS group. Between 6 months and 1 year of follow up, treatment with DES compared with BMS tended to result in fewer target lesion revascularizations. Major adverse cardiac events were similar between patients receiving DES and BMS. In octogenarians with ACS treated with IVUS-guided PCI, DES appears as safe as BMS, providing similar short- and long-term outcomes.

Predictors of Long-Term Major Adverse Cardiac Events and Clinical Restenosis following Elective Percutaneous Coronary Stenting

Angiology ◽  
2008 ◽  
Vol 60 (2) ◽  
pp. 141-147 ◽  
Author(s):  
Qiangjun Cai ◽  
Kimberly Skelding ◽  
Armstrong Arthur ◽  
Dipan Desai ◽  
G. Craig Wood ◽  
...  
Keyword(s):  
Bare Metal Stents ◽  
Coronary Intervention ◽  
Major Adverse Cardiac Events ◽  
Metal Stents ◽  
Cardiac Events ◽  
Elective Percutaneous Coronary Intervention ◽  
Adverse Cardiac Events ◽  
Percutaneous Coronary ◽  
Drug Eluting

Limited data exist regarding the predictors of long-term clinical outcomes following elective percutaneous coronary intervention (PCI) in the current era of stenting. The authors investigated the predictors of major adverse cardiac events (MACE) and clinical restenosis in 740 consecutive patients who underwent successful elective PCI with bare metal stents (BMSs) or drug-eluting stents (DESs). At 30-month follow -up, compared with BMS recipients, DES recipients had a significantly lower rate of MACE, which was mainly driven by a decreased repeat target vessel PCI. The rate of 30-month clinical restenosis was significantly lower in DES recipients. The authors conclude that baseline clinical, angiographic, and procedural characteristics determine long-term MACE and clinical restenosis after elective PCI, with DES being the independent predictor for both.

Sign in / Sign up

Export Citation Format

Share Document